Stock Track | Hims & Hers Health Soars 5.20% Intraday as Board Member Boosts Stake Amid Stock Rout

Stock Track05-27

Hims & Hers Health Inc. (HIMS) saw its stock price soar by 5.20% during intraday trading on Wednesday.

The surge followed the company's disclosure that board member David Wells purchased 48,400 shares on May 26, a move that boosted investor confidence. Wells, a financial veteran and former Netflix CFO, increased his total stake in the telehealth firm to 224,417 shares.

The insider buying activity comes as Hims & Hers stock has faced significant pressure over the past year, declining 66% from its 52-week high due to challenges including an FDA crackdown on compounded weight-loss drugs, a patent lawsuit, and a miss in quarterly results.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment